Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection

Gregory T. Everson, Karen D. Sims, Maribel Rodriguez-Torres, Christophe Hézode, Eric Lawitz, Marc Bourlière, Veronique Loustaud-Ratti, Vinod Rustgi, Howard Schwartz, Harvey Tatum, Patrick Marcellin, Stanislas Pol, Paul J. Thuluvath, Timothy Eley, Xiaodong Wang, Shu Pang Huang, Fiona McPhee, Megan Wind-Rotolo, Ellen Chung, Claudio PasquinelliDennis M. Grasela, David F. Gardiner

Research output: Contribution to journalArticlepeer-review

172 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection'. Together they form a unique fingerprint.

Medicine & Life Sciences